Recently, various executives have taken part in insider selling activity for the stocks of Athersys, Inc.(NASDAQ:ATHX), Neuralstem, Inc. (NASDAQ:CUR), Cytosorbents Corp (NASDAQ:CTSO), and Incyte Corporation (NASDAQ:INCY).

Athersys, Inc.

Chairman and CEO Gil Van-Bokkelen unloaded 9,500 Athersys shares, valued at $12,873, in two transactions dated September 18 and 21. The shares were sold via automatic sale program. Van-Bokkelen now holds 901,665 of the company’s shares that are valued at $1,208,231.

CSO John J. Harrington sold 8,150 shares, valued at $11,003, on September 18 and 21. The shares were sold via automatic sale program. Harrington now holds 531,056 of the company’s shares that are valued at $711,615.

President and COO William Lehmann disposed of 25,000 shares (6% of total stake), valued at $33,900, on September 18 and 21 as well. The shares were sold via automatic sale program. Lehmann now holds 376,049 of the company’s shares that are valued at $503,906.

Click Here to see the performance of Athersys insiders.

Neuralstem, Inc.

CSO Karl Johe yesterday unloaded 25,000 Neuralstem shares (2% of total stake), valued at $38,000. The shares were sold via automatic sale program. Johe now holds 1,026,304 of the company’s shares that are valued at $1,549,719.

Click Here to see the performance of Neuralstem insiders.

Cytosorbents Corp

Director Al Kraus unloaded 10,000 Cytosorbents shares (15% of total stake), valued at $66,300, in a transaction dated September 17. The shares were sold via automatic sale program. Kraus now holds 55,746 of the company’s shares that are valued at $382,418.

Click Here to see the performance of Cytosorbents insiders.

Incyte Corporation

Executive Vice President and General Counsel Eric H. Siegel unloaded 2,222 Incyte shares (39% of total stake), valued at $290,393, in a transaction dated September 17. The shares were sold via automatic sale program. Siegel now holds 3,355 of the company’s shares that are valued at $398,104.

Click Here to see the performance of Incyte insiders.